News

John S. Clark Joins Abt Bio-Pharma Solutions, Inc., as Director, Commercial Strategy Group

Lexington, MA. December 11, 2009– John S. Clark, M.P.P., a market strategist with more than 20 years experience in the global bio-pharmaceutical, medical technology and device sectors, has joined Abt Bio-Pharma Solutions, Inc. (ABS), as Director, Commercial Strategy Group. Mr. Clark will work closely with ABS clients to help them address the many challenges to successful commercialization that exist in today's competitive healthcare market.

"Our clients are already familiar with Nandini Hadker's special talent for understanding their business needs and addressing them through insightful market-research and consultation." said Steve Fosburg, ABS President. "John shares her deep business and methodological knowledge and passionate commitment to supporting our clients and ensuring that they achieve their business goals both short- and long-term. We are delighted to add him to our team."

Mr. Clark was previously Senior Vice President and Senior Consultant at Harris Interactive, responsible for directing a global full-service market research practice and for serving as Chair of Strategic Health Perspectives, a highly respected healthcare market forecasting service delivered in collaboration with the Harvard School of Public Health. Mr. Clark began his career directing emergency and dialysis services for a major hospital in New York State.

"The Commercial Strategy Group is growing rapidly to meet our clients' needs for our specialized and differentiated services. I am thrilled to add senior leadership of John Clark's caliber to the team to support our value proposition as the "go-to" research and consulting team for our clients," said Nandini Hadker, Executive Director.

Mr. Clark earned his Masters in Public Policy with a major in Health Policy from Georgetown University and his B.A. from the University of Toronto. He received his certification as a Qualitative Moderator from the RIVA Training Institute.

The ABS team has provided integrated strategic, research and commercialization services to the pharmaceutical, biotechnology, medical device and diagnostics industries for more than 20 years. The company specializes in demonstrating the value, safety, and efficacy of health technologies through qualitative and quantitative market research, prospective studies such as registries as well as through retrospective data analyses, economic models, and technical publications in peer-reviewed clinical journals. ABS teams of senior, seasoned staff help clients develop their research agendas, successfully conduct their research programs, and communicate the results to internal and external audiences. Primary service offerings include strategic commercialization services, health economics and outcomes research, pricing and reimbursement, registries and other late-phase clinical studies.

Contact

Julia Altman
Director of Marketing
781.372.6658
julia.altman@abtbiopharma.com